Short-term Evaluation of Motor and Sensory Function in Post-COVID-19 Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-01

Study Completion Date

2022-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

SARS-COV-2 infection reframed medical knowledge in many aspects, yet there is still a lot to be discovered. our aim is to evaluate neurological impact of covid-19; if there is any.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pattern and Frequency of Non-epileptic Involuntary Movements

NCT04083586

Involuntary Movements

COMPLETED

Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With NMD

NCT04581577

Neuromuscular Diseases Neurological Diseases or Conditions

COMPLETED

Movement Disorders in Multiple Sclerosis Patients

NCT05973929

Multiple Sclerosis Movement Disorders

UNKNOWN

Study of Epidemiologic Investigation and Mechanism of Brain Network of Otologic and Cognitive Function With Post-COVID-19

NCT05787301

COVID-19 Cognitive Decline Otological Disease

COMPLETED

Cortical Excitability and Typing Performance After Action Observation and Motor Execution

NCT07009561

Young Adults

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Coronavirus disease 19 (COVID-19) can cause neuropsychiatric, psychological and psychosocial impairments. Literature regarding the sensory and motor affection of COVID-19 is still limited.

Public health emergencies as COVID-19 are likely to cause adverse neuropsychiatric impacts. Cognitive impairments after SARS-COV-2 infection were noticed, COVID-19 patients complain of poor concentration, declined memory, and insomnia, as well as anxiety and depression symptoms.

in a study; Neurological manifestations described in 36.4% of 214 patients with confirmed COVID-19. However, the symptoms described \[dizziness (not further defined), headache, and impaired consciousness\] are commonplace in many severe infections and represent disturbances in neurological function rather than a neurological disease per se. Anosmia and ageusia have received much attention, but are ubiquitous in other common upper respiratory tract infections. While a reported increased risk of cerebrovascular disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Motor Neuropathy Sensory Neuropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Covid-19 Group

Motor nerve study was performed in the median and posterior tibial nerve to assess the motor function of the upper and lower limbs.

Sensory nerve study was done for the median and sural nerves to estimate the peripheral neurological function of both upper and lower limbs.

F wave study was performed for the upper limb in the median nerve.

No interventions assigned to this group

Control Group

Motor nerve study was performed in the median and posterior tibial nerve to assess the motor function of the upper and lower limbs.

Sensory nerve study was done for the median and sural nerves to estimate the peripheral neurological function of both upper and lower limbs.

F wave study was performed for the upper limb in the median nerve.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with confirmed RT-PCR COVID-19 infection with mild to moderate severity based on the Egyptian ministry of health (MOH) protocol (version 1.4, November 2020) with neurological symptoms suggestive of peripheral neuropathy

Exclusion Criteria

* patients presenting with neurological manifestations other than peripheral neuropathy, such as stroke, cerebral hemorrhage, encephalitis, or meningitis.
* Patients with any medical condition or comorbidities that may affect the result of the study as diabetes, arthritis, and carpel tunnel syndrome.
* Severe COVID-19 patients with a critical condition that needs hospitalization and ventilatory support were also excluded from the study.

Minimum Eligible Age

20 Years

Maximum Eligible Age

68 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes